Rheumatology Clinical Trials Office is categorized under Medical Labs in Clarksburg, WV and active since 2008.
Rheumatology Clinical Trials Office was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Amie Jones at the company’s single location by writing to 395 Emily Drive, Clarksburg, West Virginia WV 26301 or by phoning (304) 622-0963. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rheumatology Clinical Trials Office |
| Contact Person: | Amie Jones |
| Address: | 395 Emily Drive, Clarksburg, West Virginia 26301 |
| Phone Number: | (304) 622-0963 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Rheumatology Clinical Trials Office was started in 2008 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Amie Jones for inquiries that concern Rheumatology Clinical Trials Office by calling the company number (304) 622-0963, as your correspondence is most welcome. Additionally, the physical location of the single location of Rheumatology Clinical Trials Office can be found at the coordinates 39.27076,-80.285534 as well as the street address 395 Emily Drive in Clarksburg, West Virginia 26301.
For its online presence, you may visit Rheumatology Clinical Trials Office’s website at and engage with its social media outlets through on Twitter and on Facebook.